A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

Bill: 115-s-1960
Sponsor: full_name: Sen. McCaskill, Claire [D-MO]
Introduced: 2017-10-16
Policy area: Crime and Law Enforcement
Subjects: Drug trafficking and controlled substances

Licensing and registrations

Prescription drugs

Retail and wholesale trades
Latest action: action_date: 2017-10-16
text: Read twice and referred to the Committee on the Judiciary.

Summaries:
action_date: 2017-10-16
action_desc: Introduced in Senate
text: <p>This bill repeals two sections of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and the amendments made by such sections to the Controlled Substances Act. The repealed sections modified registration and enforcement authorities of the Drug Enforcement Administration with respect to manufacturers, distributors, and dispensers of controlled substances. </p>

tv_txt: II 115th CONGRESS 1st Session S. 1960 IN THE SENATE OF THE UNITED STATES October 16, 2017 Mrs. McCaskill (for herself, Mr. Manchin , and Ms. Hassan ) introduced the following bill; which was read twice and referred to the Committee on the Judiciary A BILL To repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

1. Repeal of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (a) Registration process under the Controlled Substances Act Sections 1 and 2 of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 ( Public Law 114–145 ; 130 Stat. 354) and the amendments made by such sections are repealed. (b) Technical and conforming amendments (1) Definitions (A) Factors as may be relevant to and consistent with the public health and safety Section 303 of the Controlled Substances Act ( 21 U.S.C. 823 ) is amended by striking subsection (j). (B) Imminent danger to the public health or safety Section 304(d) of the Controlled Substances Act ( 21 U.S.C. 824(d) ) is amended— (i) by striking (d)(1) The Attorney General and inserting (d) The Attorney General ; and (ii) by striking paragraph (2). (2) Opportunity to submit corrective action plan prior to revocation or suspension Section 304(c) of the Controlled Substances Act ( 21 U.S.C. 824(c) ) is amended— (A) by striking paragraphs (2) through (5); (B) by striking (c)(1) Before and inserting (c) Before ; and (C) by adding at the end the following: The order to show cause shall contain a statement of the basis thereof and shall call upon the applicant or registrant to appear before the Attorney General at a time and place stated in the order, but in no event less than thirty days after the date of receipt of the order. Proceedings to deny, revoke, or suspend shall be conducted pursuant to this section in accordance with subchapter II of chapter 5 of title 5, United States Code. Such proceedings shall be independent of, and not in lieu of, criminal prosecutions or other proceedings under this title or any other law of the United States. .